ArticleJournal of molecular medicine (Berlin, Germany)2021

The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.

Kota Araki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.